A “two-for-one” cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scientists from UPMC Hillman Cancer Center who led an… Read more
Category: University of Pittsburgh School of Medicine
Pitt TB Vaccine Discovery Paves Path to End No. 1 Killer of People Living with HIV
Scientists at the University of Pittsburgh School of Medicine have discovered a tuberculosis (TB) vaccination strategy that could prevent the leading cause of death among… Read more
Innovative Pitt-Led Research Extended to Unravel Mysteries of Dysfunctional Blood Clotting in Trauma Patients
Dr. Matthew Neal, co-director of the Trauma and Transfusion Medicine Research Center at the University of Pittsburgh School of Medicine and director of emergency general… Read more
Pitt Surveillance System Detected Infection Linked to Eye Drops Months Before Outbreak Declared
An infectious diseases surveillance system created by University of Pittsburgh School of Medicine scientists and deployed at a UPMC hospital successfully flagged cases of a… Read more
Cancer-Infecting Virus ‘Warms Up’ Cold Tumors and Improves Immunotherapy
Equipping cancer-infecting, or oncolytic, viruses with tumor-inhibiting genetic cargo stimulates the immune system and helps immunotherapy to shrink or completely clear aggressive tumors in mice,… Read more